1. Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma
   Jeong-Yeol Park et al, 2018, Virchows Arch CrossRef
2. Effects of leuprorelin for the treatment of recurrent gynecological cancer by assessment including self-administered quality-of-life questionnaire
   Hiroshi Tsubamoto et al, 2018, J. Obstet. Gynaecol. Res. CrossRef
3. Recent advances in the histological and molecular classification of endometrial stromal neoplasms
   Joana Ferreira et al, 2018, Virchows Arch CrossRef
4. The 2017 hormone therapy position statement of The North American Menopause Society
   , 2018, Menopause CrossRef
5. Ovarian preservation for low-grade endometrial stromal sarcoma: a systematic review of the literature and meta-analysis
   Dimitrios Nasioudis et al, 2019, Int J Gynecol Cancer CrossRef
6. Hormonal therapy in uterine sarcomas.
   Yuqin Zang et al, 2019, Cancer Med CrossRef
7. Hormone therapy following surgery in low-grade endometrial stromal sarcoma
   Gunsu Kimyon Comert et al, 2019, Journal of the Chinese Medical Association CrossRef
8. Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosis
   Diane Pannier et al, 2019, Critical Reviews in Oncology/Hematology CrossRef
9. Uterine sarcoma Part II—Uterine endometrial stromal sarcoma: The TAG systematic review
   Huann-Cheng Horng et al, 2016, Taiwanese Journal of Obstetrics and Gynecology CrossRef
10. The 2017 hormone therapy position statement of The North American Menopause Society
    , 2017, Menopause CrossRef
11. Endometrial stromal sarcoma in combination with mixed type endometrial carcinomas
    Xiao-Xin Xiu et al, 2017, Medicine CrossRef
12. Hormonal management of menopausal symptoms in women with a history of gynecologic malignancy
    Benjamin S. Harris et al, 2020, Menopause CrossRef
13. Endometrial stromal sarcoma: A review of rare mesenchymal uterine neoplasm
    V.A. Capozzi et al, 2020, J. Obstet. Gynaecol. Res. CrossRef
14. Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma
    S. Cabrera et al, 2020, Clin Transl Oncol CrossRef
15. Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903)
    M. Friedlander et al, 2021, Gynecologic Oncology CrossRef
16. The prognosis of recurrent low-grade endometrial stromal sarcoma: a retrospective cohort study.
    Lei Li, 0 CrossRef
17. Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?
    Saikat Mitra et al, 2022, Cancers CrossRef
18. New Insights into Hormonal Therapies in Uterine Sarcomas
    Elena Maccaroni et al, 2022, Cancers CrossRef
19. null
    Emily Hinchcliff et al, 2023 CrossRef
20. Sarcoma do estroma endometrial metastático em paciente com sangramento uterino anormal refratário: relato de caso
    Samya Hamad Mehanna et al, 2024, J bras Ginec CrossRef
21. Endometrial stromal sarcoma: A rare tumor with therapeutic conundrums
    Sunil Pasricha et al, 2020, Cancer Res Stat Treat CrossRef